Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects

Overview of attention for article published in Birth Defects Research Part A: Clinical and Molecular Teratology, November 2011

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#12 of 576)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 8 news outlets
blogs: 2 blogs
policy: 2 policy sources
twitter: 4 X users

facebook: 12 Facebook pages
googleplus: 2 Google+ users
reddit: 1 Redditor
guideline: 3 clinical guideline sources

Readers on

mendeley: 134 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 10 news stories from 8 outlets.

Ondansetron: New and troubling data

Pediatric News , 03 Nov 2025

For some time, the potent antiemetic ondansetron, a 5-HT3 receptor antagonist approved for preventing nausea and vomiting…

Relegate Ondansetron to Auxiliary Role in Pregnancy

Medical Health News, 01 Mar 2019

Figure A slew of investigations over the years have found varying rates of birth defects among pregnant women taking ondansetron…

News story from Vice on Monday 21 November 2016

Vice, 21 Nov 2016

Most Drugs Aren’t Tested on Pregnant Women. This Anti-nausea Cure Shows Why That’s a Problem

ProPublica, 26 May 2016

This story was co-published with Mother Jones and AL.com. Marquita Smiley’s first surprise was discovering she was pregnant.

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 6 additional news stories.